Fertility News and Research

RSS

Study shows that satisfaction of older parents rise with more number of children

The satisfaction of young parents decreases with their number of children, while older parents are happier than their childless peers.

8 Mar 2011

CPCHE launches multi-year project to promote healthier home energy retrofits

Home energy retrofits tackle climate change and when done right they should make homes healthier, while aiding families struggling with utility bills.

6 Mar 2011

HCI creates Pediatric Cancer Late Effects Clinic to help manage long-term issues of treatment

Although cancer in children is rare, more than 10,000 children in the United States are diagnosed with some form of the disease every year. If these children survive, studies have found that more than two-thirds develop at least one late-effect of treatment, which can include additional cancers, fertility and heart problems, limited limb function, and hearing loss.

1 Mar 2011

Aeterna Zentaris receives $2.5M net sales milestone payment from Cowen Royalty

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that it had received a net sales milestone of $2.5 million from Cowen Healthcare Royalty Partners, L.P..

28 Feb 2011

Stress & infertility treatment success unrelated: Study

British researchers from Cardiff University looked at 14 studies that included a total of 3,583 women who had undergone fertility treatment and been assessed for anxiety and stress before they began their therapy. They compared women who became pregnant and those who did not and noted that there was no association between emotional distress and the likelihood of becoming pregnant. The results were published in the online edition of British Medical Journal on Feb. 24.

28 Feb 2011

Genentech granted FDA hearing on Avastin for metastatic breast cancer

Genentech, a member of the Roche Group, today announced the U.S. Food and Drug Administration (FDA) has granted a hearing to allow the company the opportunity to present its views on why Avastin® (bevacizumab) should remain FDA-approved for metastatic breast cancer (mBC). The FDA has scheduled the hearing for June 28 to 29, 2011.

25 Feb 2011

G-CSF treatment improves inadequate endometrium during IVF cycles

During in vitro fertilization cycles, treatment with a medication called granulocyte-colony stimulating factor significantly improves inadequate endometrium, according to a report published electronically on February 15 in Fertility and Sterility - the official journal of the American Society for Reproductive Medicine.

24 Feb 2011

New study: PCBs linked to embryo implantation failure during IVF

According to a new study published February 24 in the peer-reviewed journal Environmental Health Perspectives, serum polychlorinated biphenyls at concentrations found in the general U.S. population are associated with the failure of fertilized embryos to implant in the uterus after in vitro fertilization.

24 Feb 2011

Pretreatment with FDA-approved drug allows successful pregnancies in radiation-exposed rhesus monkeys

A strategy developed by Massachusetts General Hospital (MGH) researchers to shield the ovaries of female mammals from the damaging effects of radiation and chemotherapy has passed an important milestone. A collaborative study with investigators from Oregon Health and Sciences University (OHSU), published online in the journal Fertility and Sterility, reports that brief preexposure of the ovaries to an FDA-approved agent called FTY720 preserved the fertility of female rhesus monkeys exposed to potentially lethal doses of radiation.

23 Feb 2011

The AFA initiates 2011 College Tour to educate young men and women about infertility

The American Fertility Association (The AFA), a national family-building non-profit organization, is heading to college campuses around the country to educate young men and women about infertility - a disease affecting one out of 6 couples in the U.S. The 2011 College Tour Series kicks off on March 4th at the University of Colorado in Boulder.

21 Feb 2011

New research suggests prevention of unwanted births may decline fertility rates

While many researchers generally credit the desire for smaller families for the decline in fertility rates in developing, low-income countries, new research suggests that prevention of unwanted births may actually be a larger factor.

21 Feb 2011

Skeleton regulates fertility in males, but not females

Researchers at Columbia University Medical Center have discovered that the skeleton acts as a regulator of fertility in male mice through a hormone released by bone, known as osteocalcin.

17 Feb 2011

Metallic copper surfaces kill bacteria on contact

Metallic copper surfaces kill microbes on contact, decimating their populations, according to a paper in the February 2011 issue of the journal Applied and Environmental Microbiology. They do so literally in minutes, by causing massive membrane damage after about a minute's exposure, says the study's corresponding author, Gregor Grass of the University of Nebraska, Lincoln. This is the first study to demonstrate this mechanism of bacteriocide.

17 Feb 2011

State court jury rules in favor of Merck in FOSAMAX trial

Merck & Co., Inc. today said a state court jury in New Jersey found in its favor in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use.

15 Feb 2011

Resources attributable to career, family-related choices set women back in science, technology fields

It's an incendiary topic in academia - the pervasive belief that women are underrepresented in science, math and engineering fields because they face sex discrimination in the interviewing, hiring, and grant and manuscript review processes.

10 Feb 2011

Vitrolife fourth quarter sales increases 20% to SEK 81 million

A quarter with record sales concluded a year that set the stage for an increased potential in growth.

9 Feb 2011

Genentech's OCEANS Phase III study of Avastin in platinum-sensitive ovarian cancer meets primary endpoint

Genentech, a member of the Roche Group, announced today that OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) followed by continued use of Avastin alone until disease progression in women with previously treated (recurrent), platinum-sensitive ovarian cancer, met its primary endpoint.

8 Feb 2011

North Shore-LIJ begins patient enrollment in epilepsy research study

In the United States, epilepsy affects nearly one million women of childbearing potential and whether there is increased infertility in women with epilepsy is presently unknown. People with epilepsy have been reported to have fewer children, however, the specific factors contributing to this lower birth rate are unknown.

5 Feb 2011

Merck reports GAAP net income of $861 million for 2010

Merck, known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88, which excludes purchase accounting adjustments, restructuring costs and merger-related expenses.

4 Feb 2011

First ever story-collective for people involved in reproductive technologies

AnonymousUs.org, a newly launched website, invites anyone and everyone involved in reproductive technologies to write about their experiences and opinions—anonymously. It is especially designed to encourage those conceived via reproductive technologies to share their personal stories without shame or fear.

4 Feb 2011